Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.26 -0.30 (-3.14%)
As of: Oct 1, 2026 · 3:40 PM EDT

Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021)

Updated

Xeris Biopharma Holdings (XERS) recorded Capital Expenditures of $131,000 in Q4 2021, down 41.8% from $225,000 a year earlier.

Analysis

Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021) Analysis & Trends

For FY2021, Xeris Biopharma Holdings reported Capital Expenditures of $1.09 million, up 187.8% from FY2020.

  • Across earlier years, Capital Expenditures came in at $377,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 131,000.00
Dec 31, 2020 225,000.00
API Access

Xeris Biopharma Holdings Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XERS&period=max&api_key=YOUR_API_KEY